Common Beginner Mistakes to Avoid
Most first-timers assume the risk is in the injection. It usually isn't. The expensive mistakes happen weeks earlier — in what you buy, what you skip, and what you never measured.
This guide covers the failure modes that most often waste a beginner's money, time or health, organised in the order they tend to occur. It is educational only and not a substitute for advice from a qualified healthcare professional. Sources are listed at the end.
Ask someone new to peptides what worries them and they will usually say the needle. Then they will spend forty minutes researching injection angles and about four minutes deciding which compound to buy and from whom.
That ratio is backwards. Injection technique is worth getting right, and there is a whole page on it — but it is a solved problem with clear answers. The mistakes that actually cost people are earlier, quieter, and mostly invisible at the time you make them.
The needle is the visible part. It is rarely the part that determines whether this works out.
Before You Buy
1. Picking a compound before defining the problem
The usual sequence is backwards: someone hears about a compound, gets interested, then reverse-engineers a reason to want it. What follows is months of running something that was never matched to a goal, with no way to tell whether it did anything.
Write down what you are actually trying to change, specifically enough that you would recognise success. "More energy" is not that. "I want to stop needing a nap at three o'clock" is. The specific version tells you what to measure, and often tells you that the answer is not a peptide at all. Our guide to choosing your first peptide and the overview of the different types of peptides both work from goal to compound rather than the reverse.
2. Skipping the medical question
Two versions of this, and both are common.
The first is not checking whether the symptom has a diagnosable cause. Fatigue, poor concentration, low libido and stalled body composition are all things peptides get bought for, and all four are also how thyroid dysfunction, anaemia, sleep apnea, depression and low testosterone present. Those are cheap to test for and actually treatable. Spending six months and several hundred dollars on a research compound while an underlying condition goes unaddressed is the most expensive mistake on this page.
The second is not checking interactions. If you take anything prescribed — particularly for diabetes, blood pressure, thyroid, mood or sedation — that conversation comes before the purchase, not after the first dose. Interaction data for most research peptides does not exist, which is a reason for more caution rather than less. See peptide drug interactions and when to consult a doctor.
3. Starting with no baseline
You cannot detect a change from a starting point you never recorded. Two weeks of tracking before you begin costs nothing and is the difference between knowing and believing.
What to record depends on the goal: weight and measurements, a repeatable performance test, sleep duration, a simple daily rating of the thing you want to change. And where the compound touches metabolism or the growth hormone axis, bloodwork before you start is worth more than any amount of subjective impression afterwards — you cannot feel a change in fasting glucose.
The reason this matters more than it sounds
Expectation produces a real, noticeable improvement in the first week or two of almost anything. Without a baseline and a measurable endpoint, you have no way to separate that from an actual effect — which means you may keep paying for something that stopped doing anything in week three, or abandon something that was working slowly.
When You Buy
4. Buying on price
This is the mistake with the hardest evidence behind it, and it is worth looking at squarely.
A 2024 study published in the Journal of Medical Internet Research test-purchased semaglutide from online sellers operating without prescription requirements and ran full analytical characterisation. The vials were labelled as 99% pure. Measured purity ranged from 7.7% to 14.37%. Bacterial endotoxin was detected in every sample tested. The researchers classified all of the purchased products as substandard, falsified or counterfeit.
One study, one compound, one slice of the market — but it is peer-reviewed, and the gap is not subtle.
Endotoxin deserves a specific mention because it is the contaminant a purity percentage will not catch. These are bacterial cell-wall fragments that survive sterilisation and cause fever and inflammation when injected. Standard purity testing does not measure them; a separate assay does, and most certificates omit it entirely.
The practical version: ask for batch-specific testing that names the lab and the date, and check whether identity as well as purity was tested. Our guide on reading a certificate of analysis covers what a real one contains, and our COA database holds the results for what we carry.
5. Misreading "research use only"
Beginners routinely read this label as a safety classification — as though the product has been checked and cleared for laboratory work. It has not. It describes a legal position taken by the seller, and it means the seller is not claiming the product is fit for people. That framing removes manufacturing, testing and labelling obligations that would otherwise apply.
No regulator verifies the purity, potency or sterility of a research-labelled peptide before it reaches a buyer, and there is no mandatory third-party testing requirement anywhere in the chain. Everything you know about a given vial comes from what the supplier chose to test and chose to publish. That is exactly why the documentation question above matters, and why research versus pharmaceutical grade is a distinction worth understanding properly.
When You Start
6. Starting several compounds at once
The single most common way beginners guarantee they learn nothing. Three compounds in one week, something happens — good or bad — and there is no way to attribute it. Now you either keep running all three forever or stop everything and restart.
Introduce one thing, give it long enough to show an effect, then add the next. It feels slower. It is dramatically faster than starting over.
7. Going straight to a full dose
Almost every compound with a meaningful side-effect profile is worst at the beginning. Starting at the top of a range front-loads all of that into week one, which is also when you are least equipped to tell an adjustment effect from a problem.
8. Expecting to feel something
Some compounds produce obvious sensations. Many produce nothing perceptible at all, because the thing they are studied for is a change in a biological marker rather than a feeling. A metabolic effect does not announce itself.
Beginners who expect a felt effect and get none tend to conclude the product is fake or the dose is too low — and then act on that conclusion, which leads directly to the next mistake.
While You're Running It
9. Chasing the dose
Nothing happened, so double it. Still nothing, so double it again. This is the most reliable route from a manageable situation to a genuinely unpleasant one, and it rests on an assumption that is often wrong — that more of something produces more of its effect.
Plenty of compounds have dose-response curves that flatten or reverse. Others produce their effect on a timescale of weeks regardless of dose. Escalating because you feel nothing at week two is treating a timing question as a dose question.
10. Silent handling errors
These are the mistakes that produce no symptom, only a quietly worthless vial.
Shaking instead of swirling
Peptides are fragile. Blast the diluent in or shake the vial and you can damage the molecule before the first dose.
Freezing reconstituted solution
Freeze-thaw damages peptide structure. Powder can be frozen; solution stays refrigerated.
Losing track of dilution
Change the water volume and every syringe mark changes. An unlabelled vial is one you cannot dose from — write the date and volume on it.
Running past the window
Bacteriostatic water carries a 28-day in-use period from first puncture. Preservative protection degrades after that regardless of technique.
Our reconstitution calculator handles the dilution maths, and the guides on reconstitution and storage in tropical climates cover the handling. The climate point is not a throwaway — a vial left on a counter in Costa Rica degrades faster than the same vial in a temperate country.
11. Not stopping when something is wrong
The last one, and the only one on this page that can hurt you rather than waste your money. There is a difference between an adjustment effect that settles over a couple of weeks and a signal that something is wrong — and the instinct to push through, having already paid for the vial, works against telling them apart.
Anything getting worse rather than better is not adaptation. Anything interfering with eating, drinking or sleeping has stopped being an inconvenience. And a handful of symptoms are not side effects to manage at all: signs of an allergic reaction, severe abdominal pain, chest pain, fainting, or a mole changing appearance on any melanocortin compound. Our page on common side effects covers the range, and when to consult a doctor covers the thresholds.
Ranked by What They Cost
Not all of these are equal. If you only fix a few, fix the ones near the top.
| Mistake | What it costs | How hard to fix |
|---|---|---|
| Skipping the medical question | Months of delay on a condition with a real treatment; possible interaction harm | One appointment |
| Not stopping when something is wrong | The only entry here that can cause lasting harm | Knowing the thresholds in advance |
| Buying on price | The full purchase, plus whatever the contaminants do | Ask for batch testing before ordering |
| Chasing the dose | Side effects that were entirely avoidable | Hold and wait instead |
| No baseline | You never find out whether it worked | Two weeks of notes |
| Several at once | Every conclusion you draw is unreliable | Stagger them |
| Handling errors | A degraded vial and a false negative | A label and a fridge |
If You've Already Made One
Most of these are recoverable, and none of them is a reason to feel foolish — the information environment around this subject is genuinely bad, and the confident protocols circulating online are mostly written by people with something to sell.
- Started three things at once? Stop the two you are least attached to, hold the third, and reintroduce one at a time. You lose a few weeks and regain the ability to interpret anything.
- No baseline? Start one now. A baseline taken mid-protocol is still useful for everything that happens next.
- Not sure what is in the vial? Ask the supplier for the batch testing. If they cannot produce it, that answers a different question.
- Escalated the dose and feel unwell? Go back down or stop. Nothing about having already bought it obliges you to finish it.
- Never had the medical conversation? Have it now. Bring what you are taking, honestly. Clinicians are considerably harder to shock than people expect.
Common Questions
What's the single biggest beginner mistake?
Treating a symptom with a research compound before finding out whether it has a diagnosable cause. Everything else on this page costs money or time. That one can cost you the window in which a real condition was easy to treat.
How long should I run something before deciding it doesn't work?
Longer than most people do, and it depends on the compound and the endpoint. Effects that run through gene expression or tissue change take weeks. The more useful question is whether you defined in advance what "working" would look like — without that, no amount of time produces an answer.
Is it a mistake to start with an injectable?
No. The route is not the risky part, and oral versions of most peptides deliver far less than the label implies because digestion destroys them. Injection anxiety is normal and usually resolves after two or three attempts with a short, fresh needle.
Should I trust protocols I find in forums?
Treat them as a starting point for questions, not as instructions. Most circulating figures have no traceable origin — they were inherited from an earlier post that inherited them from somewhere else. Ask where a number came from. If the answer is a study, read what the study actually did; the dose is often a different route or a different species.
How do I know if a supplier is legitimate?
Batch-specific testing that names the laboratory and the date, covering identity as well as purity, and ideally endotoxin. A certificate with no lot number, no lab and no date could belong to any vial. Willingness to answer a technical question directly is the other useful signal.
Is cycling necessary for a beginner?
The confident schedules online mostly come from convention rather than from studies of tolerance to those specific compounds. For a beginner the more useful discipline is a defined trial period with a defined endpoint — decide up front how long you will run it and what would count as a result.
What if I can't afford bloodwork?
Then the honest comparison is between spending that money on tests and spending it on a compound you will not be able to evaluate. Bloodwork in Costa Rica is generally more accessible than people expect, and a basic panel costs less than a couple of vials. If it genuinely is not possible, at minimum record objective non-blood measures and be more conservative about anything touching glucose or hormones.
Can I ask you what to take?
We can tell you what the research supports and what it doesn't, what a compound is studied for, and when we think the honest answer is that nothing in our catalogue fits. We cannot tell you what to take — that is a clinical judgement about you specifically, and anyone selling you something who claims otherwise is doing you a disservice.
New to this and want a sanity check?
Tell us what you're considering and why. We'll give you a straight read — including when the answer is "see a doctor first" or "that won't do what you're hoping." No pressure, no upsell.
Contact Us on WhatsAppImportant disclaimer: The information in this guide is general educational content only. It is not medical advice, a prescription, or a personalized recommendation, and nothing here should be read as encouraging the use of any compound. No dosing figures appear on this page by design. Most peptides sold by Peptides Costa Rica are not approved by the FDA, the EMA, or Costa Rica's Ministerio de Salud as finished pharmaceutical drugs for human use and are sold as research compounds intended for laboratory and scientific study; a minority of peptide medicines hold approvals for specific indications. "Research use only" labelling describes a legal position taken by a seller and is not a safety classification, a certification, or an indication that a product has been tested or cleared for any purpose. No regulatory body verifies the identity, purity, potency or sterility of research-labelled peptides before sale, and there is no mandatory third-party testing requirement; product quality varies substantially between suppliers. The purity findings described are drawn from a published analysis of a specific compound purchased from specific unregulated online sellers and should not be taken as representative of every supplier or product. Persistent symptoms including fatigue, poor concentration, low libido and unexplained changes in body composition can indicate underlying medical conditions that require diagnosis and have established treatments; these should be investigated by a qualified healthcare professional. Anyone taking prescription medication should consult their prescriber before using any peptide, as interaction data does not exist for most of these compounds. Symptoms suggesting an allergic reaction, severe abdominal pain, cardiovascular distress, or changes to pigmented skin lesions require immediate medical attention and must not be self-managed. Always consult a qualified healthcare professional before beginning any peptide protocol. Products sold by Peptides Costa Rica are intended for laboratory and research purposes only.
- Journal of Medical Internet Research (Ashraf, Mackey, Vida, Fittler et al., 2024): Market surveillance and test-purchase analysis of semaglutide sold online without prescription; measured purity of 7.7% to 14.37% against 99% label claims, bacterial endotoxin detected in all samples, and all products classified as substandard, falsified or counterfeit.
- U.S. Food and Drug Administration warning letters to online peptide sellers (2025): Statement that "research use only" and similar labelling does not exempt sellers where evidence establishes intended human use, and that drugs circumventing regulatory safeguards may be contaminated, counterfeit, or contain varying or different ingredients.
- United States Pharmacopeia and FDA guidance on injectable products: Bacterial endotoxin limits for parenteral administration, and the requirement for endotoxin testing separate from chromatographic purity assessment.
- United States Pharmacopeia monographs and manufacturer datasheets: Composition of bacteriostatic water and the 28-day in-use period following first puncture of a multi-dose vial.
- Published injection technique consensus recommendations: Guidance on needle reuse, site rotation, vial stopper disinfection and handling of multi-dose vials.
